Skip to content

Astrana Health, Inc.: 10-Q filed 2013-12-20

What Astrana Health, Inc. reported in its quarterly report filed 2013-12-20 (fiscal Q3 2013): 31 published measures, 83 facts as tagged in accession 0001144204-13-068393.

This filing

Form
10-Q (quarterly report)
Filed
2013-12-20
Fiscal period
fiscal Q3 2013
Accession
0001144204-13-068393 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Astrana Health, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-10-313,246,326USD
At 2013-01-313,223,085USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-10-314,292,564USD
At 2013-01-313,614,464USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-10-31-779,210USD
At 2013-01-31-354,876USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-10-311,012,290USD
At 2013-01-311,176,727USD
At 2012-10-31500,964USD
At 2012-01-31164,361USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-08-01 to 2013-10-31-1,014,646USD92
2013-02-01 to 2013-10-31-3,395,878USD273
2012-08-01 to 2012-10-31-4,721,401USD92
2012-02-01 to 2012-10-31-8,081,583USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-02-01 to 2013-10-31-928,745USD273
2012-02-01 to 2012-10-31260,948USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-02-01 to 2013-10-3113,859USD273
2012-02-01 to 2012-10-3113,459USD274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2013-08-01 to 2013-10-312,605,231USD92
2013-02-01 to 2013-10-317,644,843USD273
2012-08-01 to 2012-10-311,965,153USD92
2012-02-01 to 2012-10-315,246,448USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-02-01 to 2013-10-31878,167USD273
2012-02-01 to 2012-10-3175,000USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-02-01 to 2013-10-31-113,859USD273
2012-02-01 to 2012-10-31655USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-10-31-14,418,150USD
At 2013-01-31-11,022,272USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-08-01 to 2013-10-3131,956USD92
2013-02-01 to 2013-10-3141,360USD273
2012-08-01 to 2012-10-310USD92
2012-02-01 to 2012-10-314,800USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-10-3162,435USD
At 2013-01-3168,142USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-02-01 to 2013-10-319,475USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-08-01 to 2013-10-31-813,487USD92
2013-02-01 to 2013-10-31-2,885,846USD273
2012-08-01 to 2012-10-31-1,437,225USD92
2012-02-01 to 2012-10-31-1,553,404USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-10-312,644,304USD
At 2013-01-312,872,122USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-08-01 to 2013-10-31178,679USD92
2013-02-01 to 2013-10-31476,978USD273
2012-08-01 to 2012-10-31221,239USD92
2012-02-01 to 2012-10-31670,181USD274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-10-312,094,003USD
At 2013-01-311,704,750USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2013-10-31258,200USD
At 2013-01-3133,200USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-10-311,475,980USD
At 2013-01-311,582,505USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-08-01 to 2013-10-311,278,103USD92
2013-02-01 to 2013-10-314,163,188USD273
2012-08-01 to 2012-10-311,603,421USD92
2012-02-01 to 2012-10-312,466,563USD274

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2013-08-01 to 2013-10-31464,616USD92
2013-02-01 to 2013-10-311,277,342USD273
2012-08-01 to 2012-10-31166,196USD92
2012-02-01 to 2012-10-31913,159USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-10-3137,977,607shares
At 2013-01-3134,843,441shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-10-3113,942,598USD
At 2013-01-3111,248,566USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2013-10-31-1,046,238USD
At 2013-01-31-391,379USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-10-3155,481USD
At 2013-01-3130,981USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-08-01 to 2013-10-311,271,575USD92
2013-02-01 to 2013-10-314,143,622USD273
2012-08-01 to 2012-10-311,598,373USD92
2012-02-01 to 2012-10-312,451,778USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-08-01 to 2013-10-316,528USD92
2013-02-01 to 2013-10-3119,566USD273
2012-08-01 to 2012-10-315,048USD92
2012-02-01 to 2012-10-3114,785USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-02-01 to 2013-10-3119,566USD273
2012-02-01 to 2012-10-3114,785USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2013-08-01 to 2013-10-31-169,203USD92
2013-02-01 to 2013-10-31-468,672USD273
2012-08-01 to 2012-10-31-3,284,176USD92
2012-02-01 to 2012-10-31-6,523,379USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-02-01 to 2013-10-31-106,525USD273
2012-02-01 to 2012-10-31252,755USD274

Inspect the source

Entity
Astrana Health, Inc. / CIK 0001083446
Captured
2026-09-20T05:20:50.832Z
SEC response SHA-256
24589a8b90ad6a7cdaab8fd1b252b61b042f4e45ec87312920857f7a3d1d7dfe

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001083446.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))